Protionamide tablet from Lekhim Joint Stock Company in Ukraine prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
News
Remington’s levofloxacin tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Lupin’s paediatric isoniazid/rifampicin dispersible tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Application of reference-scaled criteria for AUC in bioequivalence studies conducted for submission to PQT/MED
M
WHO bioequivalence guidelines (TRS No.
First dolutegravir 5mg dispersible tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
First darunavir/ritonavir tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Lab Liconsa’s ivermectin prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Naari’s levonorgestrel tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Panpharma’s oxytocin injection prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Tunggal’s medroxyprogesterone acetate depot injection prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Macleods’ dispersible sulfadoxine/pyrimethamine tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
New Invitation for Expression of Interest (EOI) to manufacturers of antituberculosis medicines published
M
The Invitation to Manufacturers of Antituberculosis Medicines to submit an Expression of Interest for Product Evaluation to the WHO Prequalification Unit was recently updated following a request by
Two PQT Medicines workshops for manufacturers: The 4th Annual Quality Workshop for Manufacturers and the 1st Biotherapeutics Workshop for Manufacturers
M
For further information see: /prequal/events/two-pqt-medicines-workshops-manufacturers
ICH Harmonised Guideline M9 “Biopharmaceutics Classification System-Based Biowaivers” implemented and updated biowaiver documentation published
M
Effective 25 May 2021 the ICH guideline M9 “Biopharmaceutics Classification System-Based Biowaivers” is implemented by PQT/MED.
Tocilizumab and sarilumab invited for COVID-19
M
Tocilizumab and sarilumab invited for COVID-19.
Macleods’ abacavir/lamivudine prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Medopharm’s praziquantel prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
New artesunate injection prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list:
Guilin’s artemether/lumefantrine dispersible tablets prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
S Kant’s SP dispersible tablet co-packed with amodiaquine dispersible tablet prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
S Kant’s pyrimethamine/sulfadoxine dispersible tablets prequalified
M
WHO Prequalification Unit (PQT) added the below new products to its prequalified list:
First albendazole prequalified
M
WHO Prequalification Unit (PQT) added the below new product to its prequalified list: